Methods Of Classifying Biological Samples For Predicting Response To Tyrosine Kinase Inhibitor Treatment
- 专利权人:
- 发明人:
- Larry E. Morrison,John Coon
- 申请号：
- US14869363
- 公开号：
- US20160017440A1
- 申请日:
- 2015.09.29
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- Gene copy numbers of signaling components downstream of EGFR identify non-small cell lung cancer (NSCLC) patients with poor outcomes on 2nd/3rd line gefitinib therapy.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Molecular Biomarkers for Predicting Response to Tyrosine Kinase Inhibitors in Lung Cancer
- Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
- MOLECULAR BIOMARKERS FOR PREDICTING RESPONSE TO TYROSINE KINASE INHIBITORS IN LUNG CANCER
- METHOD FOR PREVENTING OR TREATING TUMOR DISEASES WITH A COMBINATION OF TYROSINE KINASE INHIBITOR AND CDK4/6 INHIBITOR
- Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors
